Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Front Med (Lausanne) ; 10: 1182602, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37305123

RESUMEN

Background: Ambroxol is a widely used mucoactive drug in sputum clearance of respiratory diseases taken orally and by injection. However, there is a paucity of evidence for inhaled ambroxol in sputum clearance. Methods: This study performed a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial at 19 centers in China. Hospitalized adult patients with mucopurulent sputum and expectoration difficulty were recruited. Patients were randomized by 1:1 to receive inhalation of either ambroxol hydrochloride solution 3 mL (22.5 mg) + 0.9% sodium chloride 3 mL or 0.9% sodium chloride 6 mL twice daily for 5 days, with an interval of more than 6 h. The primary efficacy endpoint was the absolute change in the sputum property score after treatment compared to the baseline in the intention-to-treat population. Results: Between 10 April 2018 and 23 November 2020, 316 patients were recruited and assessed for eligibility, of whom 138 who received inhaled ambroxol and 134 who received a placebo were included. Patients who received inhaled ambroxol had a significantly greater decrease in the sputum property score compared with patients who received inhalation of placebo (difference: -0.29; 95% CI: -0.53 to -0.05; p = 0.0215). Compared with the placebo, inhaled ambroxol also significantly reduced more expectoration volume in 24 h (difference: -0.18; 95% CI: -0.34 to -0.03; p = 0.0166). There was no significant difference in the proportion of adverse events between the two groups, and no deaths were reported. Discussion: In hospitalized adult patients with mucopurulent sputum and expectoration difficulty, inhaled ambroxol was safe and effective for sputum clearance compared with a placebo. Clinical trial registration: [https://www.chictr.org.cn/showproj.html?proj=184677], Chinese Clinical Trial Registry [ChiCTR2200066348].

2.
Disaster Med Public Health Prep ; 16(5): 1916-1921, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33762058

RESUMEN

OBJECTIVE: The aim of this study is to evaluate the clinical characteristics and outcomes in 2019 coronavirus disease (COVID-19) patients and to help clinicians perform correct treatment and evaluate prognosis and guide the treatment. METHODS: Patients totaling 239 were diagnosed with COVID-19 and were included in this study. Patients were divided into the improvement group and the death group according to their outcome (improvement or death). Clinical characteristics and laboratory parameters were collected from medical records. Continuous variables were tested by an independent sample T test, and categorical variables were analyzed by the chi-square test or Fisher's exact test. The Cox proportional hazard regression model was used for survival analysis in death patients. The time-dependent area under curves (AUC) based on white blood cell count, lymphocyte count, neutrophil count by age, blood urea nitrogen, and C-reactive protein were plotted. RESULTS: Efficacy evaluation indicated that 99 (41.4%) patients had deteriorated, and 140 (58.6%) patients had improved. Oxygen saturation, hemoglobin levels, infection-related indicators, lymphocyte and platelet counts, C-reactive protein, serum albumin, liver and kidney function, and lactate dehydrogenase in improvement group were statistically significant between the improvement and death groups. A survival analysis revealed that comorbidities, lymphocyte counts, platelet count, serum albumin, C-reactive protein level, and renal dysfunction may be risk factors in patients with COVID-19. CONCLUSION: Patients with comorbidities, lower lymphocyte counts in hemogram, platelet count and serum albumin, high C-reactive protein level, and renal dysfunction may have higher risk for death. More attention should be given to risk management in the progression of COVID-19.


Asunto(s)
COVID-19 , Enfermedades Renales , Humanos , COVID-19/epidemiología , Proteína C-Reactiva , Factores de Riesgo , Análisis de Supervivencia , Albúmina Sérica , Estudios Retrospectivos
3.
Plant Physiol Biochem ; 159: 80-88, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33341082

RESUMEN

The natural fluorescence of tree peony is short. Forcing culture, mainly by defoliation and gibberellin (GA) treatment, is frequently used for its industrial production. We previously found forcing culture to be coordinated by non-structural carbohydrates (NSCs). Herein, we further revealed the specific role of NSCs during this process. We observed that both defoliation and GA treatment increased the photosynthesis in the bracts, and defoliation had a greater effect on NSC assimilation. We further determined the NSC content and PsSWEETs expression in the bracts, and the results indicated that GA may contribute more to NSC allocation by inducing PsSWEET7. Furthermore, we determined the trehalose-6-phosphate (T6P) content and sugar signaling-related gene (PsTPS1, PsSnRK1, and PsHXK1) expression in both the petals and bracts and found that both defoliation and GA treatment induced T6P levels as well as PsTPS1 expression in both tissues. This indicated that the sugar signaling pathway may also be involved in NSC-coordinated tree peony flowering. In particular, PsSnRK1 was more rapidly induced in the bracts (as an energy shortage response) in the control plants and was completely prohibited by defoliation and GA treatment, indicating the key role of the bracts in sugar signaling. In conclusion, NSCs induced tree peony flowering both as an energy substrate and sugar signaling trigger, with the bracts playing an essential role. These results may provide further evidence on the mechanism of NSC-coordinated flower opening in tree peony under forcing culture conditions, which may also provide a foundation for improving this technology.


Asunto(s)
Carbohidratos , Flores , Paeonia , Transducción de Señal , Flores/genética , Flores/metabolismo , Regulación de la Expresión Génica de las Plantas , Paeonia/crecimiento & desarrollo , Paeonia/metabolismo , Transducción de Señal/fisiología , Azúcares , Árboles
4.
Biomed Res Int ; 2020: 5271296, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33274214

RESUMEN

Peony (Paeonia) has high ornamental, edible, and medicinal values. In order to distinguish seeds varieties, describe the proteomic profiles correlated with stress tolerance, and evaluate peony seed protein (PSP) as a functional food product, we characterized the seed protein profiles of these three species and their glucosidase inhibition activities. Results showed that the intensity of protein bands in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and specific protein ID (especially for specifically expressed proteins (SEPs)) was effective to distinguish these peony seed varieties. Proteomic analysis of the three species showed that P. ostii "Fengdan" has heat and pathogen tolerance-related proteins, while P. rockii has higher content of proteins related to cold resistance, which were all highly consistent with their adaptation of heat or cold habitat. Moreover, stress-related proteins were also accumulated in P. lactiflora Pall "Hangshao" seeds, showing its potential for stress resistance. Further protein analysis showed that the primary composition of PSP was albumin and globulin. And the solubility of PSP was good. Furthermore, PSP also showed high glucosidase inhibition activity, indicating that PSP might have some potential function for the remission of hyperglycemia. And P. ostii "Fengdan" seeds may be a better source for protein production than seeds of the other two species in terms of protein solubility and the content of total protein, albumin, and globulin. In addition, an optimal protocol of microwave-assisted alkali extraction was developed to produce PSP. In conclusion, the evaluated stress-related proteins in three peony seed species by proteomic analysis quite agreed with their adaptation of heat or cold stress; proteomics could also be a very useful tool for distinguishing species in the production; and peony seeds may be a good source for protein production.


Asunto(s)
Alimentos , Paeonia/metabolismo , Proteínas de Plantas/metabolismo , Proteómica/métodos , Semillas/metabolismo , Análisis por Conglomerados , Inhibidores de Glicósido Hidrolasas/farmacología , Concentración de Iones de Hidrógeno , Hidrólisis , Paeonia/anatomía & histología , Paeonia/fisiología , Proteoma/metabolismo , Semillas/anatomía & histología , Semillas/fisiología , Solubilidad , Factores de Tiempo
5.
Thorac Cancer ; 11(5): 1202-1210, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32153123

RESUMEN

BACKGROUND: Previous studies have shown that the dysregulation of lncRNAs participates in non-small cell lung cancer (NSCLC) development. The purpose of this study was to research the biological function of lncRNA SNHG14 and its molecular mechanism in NSCLC progression. METHODS: RT-PCR was applied for investigating the expression of SNHG14, miR-206 and G6PD. The progression of NSCLC was detected by CCK-8, Transwell and western blot assays. The targets of SNHG14 and miR-206 were measured by dual-luciferase reporter assay. RESULTS: We found a higher expression of SNHG14 in NSCLC and upregulation of SNHG14 contributed to NSCLC cell proliferation, invasion and migration. However, knockdown of SNHG14 showed the opposite effect on the progression of NSCLC. Specifically, SNHG14 negatively regulated miR-206 expression by binding with it directly. Furthermore, G6PD served as the target of miR-206. Rescue experiments showed that SNHG14 promoted G6PD expression by inhibiting miR-206. CONCLUSIONS: LncRNA SNHG14 contributed to NSCLC progression through miR-206/G6PD axis, providing novel clues for understanding the mechanism of NSCLC.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/patología , Regulación Neoplásica de la Expresión Génica , Glucosafosfato Deshidrogenasa/metabolismo , Neoplasias Pulmonares/patología , MicroARNs/genética , ARN Largo no Codificante/genética , Apoptosis , Biomarcadores de Tumor/genética , Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Movimiento Celular , Proliferación Celular , Progresión de la Enfermedad , Glucosafosfato Deshidrogenasa/genética , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/metabolismo , Células Tumorales Cultivadas
6.
Front Plant Sci ; 7: 1804, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27990149

RESUMEN

Genistein (GNT), an isoflavone, is used in the clinical treatment of various health disorders. GNT is found in primary food source plants and some medical plants. However, studies on the functions of GNT in plants are rarely reported. In this study, we demonstrated that GNT plays an important role in promoting anthocyanin accumulation in red cabbage. GNT solutions (10, 20, 30, 40, and 50 mg/L) as foliar fertilizers were applied to red cabbage. Consequently, anthocyanin accumulation in red cabbage increased in a light-dependent manner. GNT solution at 30 mg/L exhibited the optimal effect on anthocyanin accumulation, which was twice that of the control. Quantitative real-time PCR analysis indicated that GNT application upregulated the expression of all structural genes, contributing to anthocyanin biosynthesis under light conditions. Under dark conditions, GNT exerted no significant promotive effect on anthocyanin accumulation; only early biosynthetic genes of anthocyanin biosynthesis responded to GNT. The promotive effect of GNT on anthocyanin biosynthesis is directly attributable to the regulation of structural gene expression. Transcription factors exhibited no response to GNT. The levels of anthocyanin in red cabbage positively correlated with the enzyme activities of antioxidant systems. This finding correlation suggested that the promotive effect of GNT on anthocyanin levels was correlated with improved antioxidant activity in the red cabbage.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA